| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.082 | 0.6 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.11 | 0.6 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.7 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |